Discovery’s Edge: Staying one step ahead of cancer with biomarker discovery

Inside a cancer cell, locked tightly within spools of genetic text, reside the origins of each malignancy. For some cancers, a few misprints here or there enabled them to grow out of control. For others, a new juxtaposition of disparate pieces of genetic code granted the cells immunity from this rapid, malignant growth.

The exact nature of the molecular abnormalities that set the course for cancer can determine how quickly a malignancy will grow, how aggressively it might invade other tissues and how likely it will respond to certain therapies.

The Biomarker Discovery Program at Mayo Clinic is tapping into this knowledge to help physicians stay one step ahead of cancer. Read the rest of the article.
_________________________________________________________
Find more research news on Discovery's Edge.